Star Cement Limited has informed the Exchange regarding Board meeting held on November 04, 2025.
STARCEMENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.0 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Star Cement's Board, on November 4, 2025, approved unaudited standalone and consolidated results for Q2 and H1 FY26. On a standalone basis, H1 FY26 revenue from operations rose ~23% YoY to ₹1,066.4 crore (vs ₹868.4 crore in H1 FY25), and the company swung from a loss of ₹51.0 crore in H1 FY25 to a profit of ₹39.5 crore. EPS for H1 stood at ₹0.98 (vs ₹(1.26) in H1 FY25). On a consolidated basis, H1 revenue grew ~24% YoY to ₹1,722.9 crore, while PAT jumped sharply from ₹36.7 crore to ₹169.2 crore, with H1 EPS of ₹4.22. Q2 FY26 standalone revenue of ₹521.7 crore and PAT of ₹15.4 crore showed a sequential dip versus Q1 FY26 (₹544.7 crore revenue, ₹24.2 crore PAT), even though YoY growth remained strong. The Board had also approved raising up to ₹1,500 crore via private placement, preferential, rights issue, or QIP, with shareholder approval sought via postal ballot ending November 17, 2025.
Strong YoY turnaround in profitability is positive for shareholders, though the Q2 sequential slowdown in standalone numbers and the proposed ₹1,500 crore fundraise (which could dilute existing holders) are key things to watch. The share price may react to the sharp H1 profit recovery but with caution on dilution and execution of the capital plan.